Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers.
Juanjuan Hu(Donghua University), Hui Yang(Shanghai Medical College of Fudan University), Weigang Gan(Sichuan University), Aiping Tong(Chengdu Medical College), Caiying Jiang(Affiliated Hospital of Youjiang Medical University for Nationalities), Xin Tang(Sichuan University), Yu-Xin Guo(Sichuan University), Meijun Zheng(Sichuan University), Jia Ren(Shanxi Medical University), Lingyu Yu(Sichuan University), Shixi Liu(Sichuan University), Dan Lu(Harbin University of Science and Technology)
PubMed
January 1, 2019
Cited by 11
Related Papers
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
|Molecular Therapy — Oncolytics|2019|215
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis
|Contraception|2008|206
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
|Theranostics|2020|184
Stability study and optimization design of small-spacing two-well (SSTW) salt caverns for natural gas storages
|Journal of Energy Storage|2019|161